| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | Bullion Gold Discoveries Corp.: Bullion Gold Intersects 1.17 g/t Au Over 21.95 Metres in TG-09 and 1.83 g/t Au Over 12.05 Metres in TG-10 at Terragold | 575 | Newsfile | Montreal, Quebec--(Newsfile Corp. - October 20, 2026) - Bullion Gold Discoveries Corp. (TSXV: BGD) ("Bullion" or the "Company") is pleased to announce the assay results of six (6) diamond drill holes... ► Artikel lesen | |
| 08.10. | Bullion Gold Discoveries Corp: Bullion Gold drills 13.4 m of 1.73 g/t Au at Terragold | 1 | Stockwatch | ||
| BULLION GOLD DISCOVERIES Aktie jetzt für 0€ handeln | |||||
| 24.09. | Bullion Gold Discoveries Corp: Bullion Gold drills 8.4 m of 2.49 g/t Au at Terragold | 3 | Stockwatch | ||
| 23.09. | Bullion Gold Discoveries Corp.: Bullion Gold Intersects 2.49 g/t Au Over 8.4 Metres Including 13.40 g/t Au Over 1.0 Metre in DDH TG-05 at Terragold | 638 | Newsfile | Montreal, Quebec--(Newsfile Corp. - September 23, 2026) - Bullion Gold Discoveries Corp. (TSXV: BGD) ("Bullion" or the "Company") is pleased to announce the assay results of the first 4 diamond drill... ► Artikel lesen | |
| 16.09. | Bullion Gold Discoveries Corp.: Bullion Gold Launches Surface Exploration Programs at BODO and Langlade Projects | 410 | Newsfile | Montreal, Quebec--(Newsfile Corp. - September 16, 2026) - Bullion Gold Discoveries Corp. (TSXV: BGD) ("Bullion" or the "Company") is pleased to announce the launch of surface exploration programs at... ► Artikel lesen | |
| 09.09. | Bullion Gold Discoveries Corp.: Bullion Gold Returns 22.2 g/t Au + 24.5 g/t Ag over 1 metre in Channel R21 at Terragold | 548 | Newsfile | Montreal, Quebec--(Newsfile Corp. - September 9, 2026) - Bullion Gold Discoveries Corp. (TSXV: BGD) ("Bullion" or the "Company") is pleased to announce the final results of its channel sampling program... ► Artikel lesen | |
| 25.08. | Bullion Gold Discoveries Corp: Bullion Gold completes Terragold validation drilling | 1 | Stockwatch | ||
| 25.08. | Bullion Gold Discoveries Corp.: Bullion Gold Completes Terragold Validation Program with 3,909 Metres Drilled | 366 | Newsfile | Montreal, Quebec--(Newsfile Corp. - August 25, 2026) - Bullion Gold Discoveries Corp. (TSXV: BGD) ("Bullion" or the "Company") is pleased to announce the completion of its validation drilling program... ► Artikel lesen | |
| 09.07. | Bullion Gold Discoveries Corp: Bullion Gold private placement | 1 | Stockwatch | ||
| 30.06. | Bullion Gold Discoveries Corp: Bullion Gold samples 5.4 g/t Au at Terragold project | 1 | Stockwatch | ||
| 30.06. | Bullion Gold Discoveries Corp.: Bullion Reports 5.4 g/t Au and 5.0 g/t Ag in Surface Grab Sample and Commences Validation Drilling at Terragold | 483 | Newsfile | Montreal, Quebec--(Newsfile Corp. - June 30, 2026) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion" or the "Company") is pleased to provide an exploration update from Bullion's flagship and... ► Artikel lesen | |
| 23.06. | Bullion Gold Discoveries Corp: Bullion shareholders approve all matters at AGM | 1 | Stockwatch | ||
| 23.06. | Bullion Gold Discoveries Corp.: Bullion Announces Results of Annual General Meeting | 868 | Newsfile | Montreal, Quebec--(Newsfile Corp. - June 22, 2026) - Bullion Gold Discoveries Corp. (TSXV: BGD) ("Bullion" or the "Company") is pleased to announce the voting results from its Annual General Meeting... ► Artikel lesen | |
| 18.06. | XFRA NEW INSTRUMENTS AVAILABLE ON 18.06.2026 | 533 | Xetra Newsboard | The following instruments on XETRA do have their first trading 18.06.2026 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 18.06.2026
Aktien
1 SE0029278985 Tangen Industrikapital... ► Artikel lesen | |
| 17.06. | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 17.06.2026 | 512 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 17.06.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 17.06.2026ISIN NameCA1202272029 BULLION... ► Artikel lesen | |
| 17.06. | Bullion Gold Discoveries Corp: Bullion Gold closes $2-million private placement | 1 | Stockwatch | ||
| 17.06. | XFRA ISIN CHANGE | 354 | Xetra Newsboard | Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenCA1202272029 Bullion Gold Discoveries Corp. 17.06.2026 CA1199331093 Bullion Gold Discoveries Corp. 18.06.2026 Tausch... ► Artikel lesen | |
| 17.06. | Bullion Gold Discoveries Corp.: Bullion Closes $2M Private Placement | 497 | Newsfile | Montreal, Quebec--(Newsfile Corp. - June 17, 2026) - Bullion Gold Discoveries Corp. (TSXV: BGD) ("Bullion" or the "Company") is pleased to announce that it has closed its previously announced non-brokered... ► Artikel lesen | |
| 17.06. | XFRA CAPITAL ADJUSTMENT INFORMATION - 17.06.2026 | 601 | Xetra Newsboard | Das Instrument EA20 NO0013601245 EAM SOLAR AS NK -,10 EQUITY wird cum Kapitalmassnahme gehandelt am 17.06.2026 und ex Kapitalmassnahme am 18.06.2026 The instrument EA20 NO0013601245 EAM SOLAR AS NK... ► Artikel lesen | |
| 16.06. | XFRA B4R: AUSSETZUNG/SUSPENSION | 238 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILBULLION GOLD RES... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| QIAGEN | 44,935 | +4,94 % | EQS-WpÜG: Übernahmeangebot / Zielgesellschaft: Qiagen N.V.; Bieter: Crown NL Bidco B.V. | EQS-WpÜG: Crown NL Bidco B.V. / Übernahmeangebot
Übernahmeangebot / Zielgesellschaft: Qiagen N.V.; Bieter: Crown NL Bidco B.V.
21.10.2026 / 23:30 CET/CEST
Veröffentlichung einer... ► Artikel lesen | |
| MOONLAKE IMMUNOTHERAPEUTICS | 13,040 | +22,44 % | MoonLake's sonelokimab faces regulatory, commercial tests, RBC says | ||
| ARCUS BIOSCIENCES | 19,500 | +2,17 % | Arcus Biosciences prices $250M public offering at $17.50 per share | ||
| MODERNA | 199,92 | -8,65 % | Moderna wird zum Börsenstar der Krebsforschung | Noch vor wenigen Monaten war Moderna für viele Anleger vor allem ein ehemaliger Pandemiegewinner mit schrumpfenden Impfstoffumsätzen und hohen Verlusten. Inzwischen hat sich die Wahrnehmung radikal... ► Artikel lesen | |
| ARCUTIS BIOTHERAPEUTICS | 32,030 | +0,50 % | Arcutis BioTherapeutics advances 11% to new 52-week high | ||
| SUMMIT THERAPEUTICS | 15,375 | -2,87 % | Akeso, Inc.: Akeso Announces Summit Therapeutics and ECOG-ACRIN Cancer Research Group Enter into Phase II/III Clinical Trial Collaboration to Evaluate Ivonescimab in First-Line Biliary Tract Cancer | Becomes the 7th International Registrational Clinical Trial for Ivonescimab
Clinical Trial Site Activations in the United States Expected to Begin Q4 2026
HONG... ► Artikel lesen | |
| KYMERA THERAPEUTICS | 113,03 | +0,36 % | Kymera International Appoints Willson Ropp as Chief Executive Officer | Experienced specialty materials executive brings more than 30 years of leadership experience across global manufacturing, operational excellence, business integration, and long-term value... ► Artikel lesen | |
| DISC MEDICINE | 76,07 | +0,17 % | Jefferies raises Disc Medicine stock price target on drug opportunity | ||
| TANGO THERAPEUTICS | 26,920 | -0,22 % | Tango Therapeutics (TNGX) Has Striking Pancreatic Cancer Data. How Much Is Priced In? | ||
| PRAXIS PRECISION MEDICINES | 257,94 | +0,42 % | Praxis Precision Medicines, Inc.: Praxis Precision Medicines Announces Extension Period for Relutrigine for Treatment of SCN2A and SCN8A Developmental and Epileptic Encephalopathies | FDA sets updated PDUFA date of December 27, 2026 BOSTON, June 29, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a fully integrated, leading central nervous system (CNS)... ► Artikel lesen | |
| RECURSION PHARMACEUTICALS | 3,565 | -2,06 % | Cathie Wood's weekly recap: adds to CoreWeave, Meta, Recursion; cuts Personalis, Toast | ||
| BIONTECH | 81,35 | +0,18 % | Community Rückblick: BioNTech BNT113 Studie verfehlt Endpunkt: "Die Bude treibt einen zum Wahnsinn!" | © Foto: Julia Cebella - dpaBioNTech verfehlt mit BNT113 ein wichtiges Studienziel. Im wO-Forum streiten Anleger über die Zukunft der mRNA-Krebsforschung, die Bewertung der Aktie und das Potenzial der... ► Artikel lesen | |
| VERA THERAPEUTICS | 30,900 | -0,96 % | Vera Therapeutics plans FDA filing for IgAN drug in Q4 2026 | ||
| EVOTEC | 2,840 | -0,63 % | EQS-News: Evotec SE: Evotec ernennt Dr. Joanna Holbrook zur Chief Scientific Officer und Mitglied des Vorstands | EQS-News: Evotec SE
/ Schlagwort(e): Sonstiges
Evotec ernennt Dr. Joanna Holbrook zur Chief Scientific Officer und Mitglied des Vorstands
15.10.2026 / 07:30 CET/CEST
Für... ► Artikel lesen | |
| AMYLYX PHARMACEUTICALS | 29,605 | +1,98 % | Biotech Stocks At 52-Week Highs - Amylyx Pharmaceuticals +63% With Phase 3 Data, Vogenx +25%, Orchestra BioMed +19%, AtriCure, Charles River Laboratories | WASHINGTON (dpa-AFX) - The following biotech stocks reached a 52-week high on August 18, 2026, primarily driven by positive quarterly reports.Amylyx Pharmaceuticals Inc. (AMLX)Amylyx Pharmaceuticals... ► Artikel lesen |